Anti-tumor necrosis factor alpha (anti-TNF-α) is used in the treatment of rheumatic diseases not responsive to first-line regimens. Data on the safety of anti-TNF-α in HIV-infected patients are scarce and conflicting. We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
CITATION STYLE
De Nardo, P., Bellagamba, R., Corpolongo, A., Gentilotti, E., Taglietti, F., Rosati, S., … Nicastri, E. (2013). Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: A case report. Clinical and Vaccine Immunology, 20(5), 761–764. https://doi.org/10.1128/CVI.00081-13
Mendeley helps you to discover research relevant for your work.